2024 Esteemed Career Awards
The ISTH has also announced the recipients of the 2024 ISTH Esteemed Career Awards. This award is presented every year to five leaders whose career contributions have significantly advanced the scientific community’s understanding or treatment of diseases and disorders that affect hemostasis. Their career-long accomplishments are internationally regarded as exemplary models of research and mentoring excellence.
The following individuals, in the opinion of their peers and selected following a competitive review process, have been awarded:
David Gailani, M.D. (U.S.)
Gailani is Professor of Pathology, Microbiology, and Immunology and Medical Director of the Clinical Coagulation Laboratory at Vanderbilt University Medical Center, Nashville, Tennessee, USA. His research laboratory studies the biology and pathology of the plasma contact activation system and investigates methods to inhibit components of this system to produce therapeutic antithrombotic and anti-inflammatory effects.
Marilyn J. Manco-Johnson, M.D. (U.S.)
Manco-Johnson is a Pediatric Hematologist/Oncologist at the Children’s Hospital Colorado. She co-founded the National Institutes of Health (NIH) Pediatric AIDS Clinical Trials Unit in Colorado, conducting the first randomized clinical trial of prophylaxis in children with hemophilia A. She has also served as Chair of the ISTH Scientific Subcommittees on Perinatal and Pediatric Hemostasis and Women’s Health.
Robert L. Medcalf, Ph.D. (Australia)
Medcalf is Laboratory Director at Monash University in Australia and has been undertaking research into the field of fibrinolysis for over 35 years. His research has directly resulted in clinical trials related to ischemic stroke and to the repurposing of tranexamic acid. Medcalf was awarded the 2016 international prize for fibrinolysis from the International Society on Fibrinolysis and Proteolysis (ISFP), the highest accolade in this field and the first Australian honored with this award. Medcalf was also President of the ISTH 2019 Congress and previously served as Associate Editor of the Journal of Thrombosis and Haemostasis for seven years and is currently co-Editor-in-Chief of the Thrombosis Journal.
Nicola J. Mutch, Ph.D. (U.K.)
Mutch is Personal Chair at the University of Aberdeen in Scotland. She has served in leadership roles in the national and international community, including her role of Chair of the ISTH SSC. She was a part of the local planning committee for ISTH 2022 in London and Chair of Basic Science on the Annual Congress Planning Committee. Currently, she is the President of the British Society of Haemostasis and Thrombosis and serves on the editorial board of the Journal of Thrombosis and Haemostasis, as an Associate Editor for Frontiers and an Editor of Platelets.
Alok Srivastava, M.D., (India)
Srivastava is Senior Professor in the Department of Haematology, and head of the Centre for Stem Cell Research, a unit of inStem, Bengaluru, at the Christian Medical College (CMC), Vellore in India. He leads the World Federation of Hemophilia designated International Hemophilia Training Center at CMC, Vellore. Srivastava has been involved with the management of patients with bleeding disorders for over 25 years and is the President of the Indian Association for Haemophilia and Allied Disorders. He is also the chair of the steering committee of the Association for Haemophilia and Allied Disorders, Asia-Pacific. He was the chair of the FVIII/IX subcommittee of the ISTH SSC from 2006-2010 and currently serves on the SSC gene therapy steering subcommittee. He was on the board of the World Federation of Hemophilia (WFH) from 2002-2014 and served as the Vice-President (Medical) from 2012-2014. He has led the writing group for all three editions of the WFH guidelines for the management of hemophilia.